Relicord

StemCyte Inc. Extends Umbilical Cord Blood Collection Operation at Three Hospital Collection Sites in Southern California

Retrieved on: 
Wednesday, May 12, 2021
Branches of biology, Stem cells, Biology, Blood, Childbirth, Embryology, Cord blood bank, Sibling, Cord blood, Umbilical cord, Umbilical, Relicord

As these sites employ a hybrid collector-physician model, physicians and midwives will continue to collect cord blood afterhours.

Key Points: 
  • As these sites employ a hybrid collector-physician model, physicians and midwives will continue to collect cord blood afterhours.
  • This added coverage to each site allows StemCyte to be able to offer more patients the opportunity to participate in California\'s Umbilical Cord Blood Collection Program.\nThis Umbilical Cord Blood Collection Program (UCBCP) is aCalifornia statewide program administered by UC Davis Health.
  • "It is a great honor and privilege for StemCyte to be partnered with UC Davis for California\'s Umbilical Cord Blood Program (UCBCP).
  • The collection service is the state\'s first comprehensive public system for collecting cord blood that will be stored at an established, qualified cord blood bank like StemCyte.

Cord Blood & Cord Blood Banking: An Industry Overview 2020 - ResearchAndMarkets.com

Retrieved on: 
Monday, August 31, 2020
Health, Genetics, Science, Stem cells, Research, Stem cells, Branches of biology, Blood, Medical specialties, Biology, Childbirth, Cord blood bank, Sibling, Cord blood, Blood bank, Relicord, LifeCell International

In total, CBR controls over 900,000 cord blood and tissue samples, making it one of the largest cord blood banks worldwide.

Key Points: 
  • In total, CBR controls over 900,000 cord blood and tissue samples, making it one of the largest cord blood banks worldwide.
  • In Ecuador, the government created the first public cord blood bank and instituted laws such that private cord blood banks cannot approach women about private cord blood banking options during the first six months of pregnancy.
  • What are the prices for processing and storage of cord blood in private cord blood banks?
  • Cord Blood & Cord Blood Banking: An Overview
    View source version on businesswire.com: https://www.businesswire.com/news/home/20200831005345/en/

Stem Cell Umbilical Cord Blood Market to Reach $10.13 Bn, Globally, by 2027 at 16.9% CAGR: Allied Market Research

Retrieved on: 
Wednesday, August 26, 2020
Branches of biology, Biology, Stem cells, Life sciences, Cord blood, Umbilical cord, Stem-cell therapy, Regenerative medicine, Draft:CBC Health, Relicord

PORTLAND, Ore., Aug. 26, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, " Stem Cell Umbilical Cord Blood Market by Storage Service (Public Cord Blood Banks, Private Cord Blood Banks, and Hybrid Cord Blood Banks), Therapeutics (Cancer, Diabetes, Blood Diseases, Immune Disorders, Metabolic Disorders, and Other Diseases), and Application( Transplant Medicine and Regenerative Medicine): Global Opportunity Analysis and Industry Forecast, 20202027.

Key Points: 
  • PORTLAND, Ore., Aug. 26, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, " Stem Cell Umbilical Cord Blood Market by Storage Service (Public Cord Blood Banks, Private Cord Blood Banks, and Hybrid Cord Blood Banks), Therapeutics (Cancer, Diabetes, Blood Diseases, Immune Disorders, Metabolic Disorders, and Other Diseases), and Application( Transplant Medicine and Regenerative Medicine): Global Opportunity Analysis and Industry Forecast, 20202027.
  • Also, the first phase of the lockdown put off many healthcare companies from investing in the research and commercialization of cord blood stem cell therapies.
  • Based on application, the regenerative medicine segment accounted for nearly three-fifths of the global stem cell umbilical cord blood market share in 2019 and is projected to lead the trail till 2027.
  • Based on geography, North America generated the major share in 2019, garnering more than two-fifths of the global stem cell umbilical cord blood market.

Cord Blood Banking Services Market to Grow at CAGR of 10.9% from 2019 to 2027: TMR Study

Retrieved on: 
Tuesday, August 11, 2020
Stem cells, Blood, Branches of biology, Biology, Childbirth, Cord blood bank, Sibling, Cord blood, Bank, Draft:CBC Health, Relicord

As per Transparency Market Research, "While North America will account for a notable share of the global cord blood banking services market, Asia Pacific region will grow at a significant pace over the forecast period."

Key Points: 
  • As per Transparency Market Research, "While North America will account for a notable share of the global cord blood banking services market, Asia Pacific region will grow at a significant pace over the forecast period."
  • Key Findings of Global Cord Blood Banking Services Market Study:
    For a detailed analysis of global cord blood banking services market by type, and region, visit TOC at https://www.transparencymarketresearch.com/report-toc/1741
    Key Drivers of Growth in Global Cord Blood Banking Services Market:
    A string of notable growth factors is pushing the global cord blood banking services market, as per Transparency Market Research.
  • Request a sample of the study https://www.transparencymarketresearch.com/sample.php
    Regional Analysis of Global Cord Blood Banking Services Market:
    Major growth factors in the region would be technological advancement and its high adoption, high healthcare spending
    Competitive Landscape of Global Cord Blood Banking Services Market:
    In the global cord blood banking services market, the vendor landscape is quite fragmented.
  • Global Cord Blood Bank Services Market, by Type
    Global Cord Blood Bank Services Market, by Region

Cord Blood Banking Services Market to Grow at CAGR of 10.9% from 2019 to 2027: TMR Study

Retrieved on: 
Tuesday, August 11, 2020
Stem cells, Blood, Branches of biology, Biology, Childbirth, Cord blood bank, Sibling, Cord blood, Bank, Draft:CBC Health, Relicord

As per Transparency Market Research, "While North America will account for a notable share of the global cord blood banking services market, Asia Pacific region will grow at a significant pace over the forecast period."

Key Points: 
  • As per Transparency Market Research, "While North America will account for a notable share of the global cord blood banking services market, Asia Pacific region will grow at a significant pace over the forecast period."
  • Key Findings of Global Cord Blood Banking Services Market Study:
    For a detailed analysis of global cord blood banking services market by type, and region, visit TOC at https://www.transparencymarketresearch.com/report-toc/1741
    Key Drivers of Growth in Global Cord Blood Banking Services Market:
    A string of notable growth factors is pushing the global cord blood banking services market, as per Transparency Market Research.
  • Request a sample of the study https://www.transparencymarketresearch.com/sample.php
    Regional Analysis of Global Cord Blood Banking Services Market:
    Major growth factors in the region would be technological advancement and its high adoption, high healthcare spending
    Competitive Landscape of Global Cord Blood Banking Services Market:
    In the global cord blood banking services market, the vendor landscape is quite fragmented.
  • Global Cord Blood Bank Services Market, by Type
    Global Cord Blood Bank Services Market, by Region

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2020 Financial Results

Retrieved on: 
Friday, July 10, 2020
Branches of biology, Stem cells, Biology, Life sciences, Blood, Cryo-Cell International, Childbirth, Cord blood bank, Cloning, Cord blood, Cryo-Save, Relicord

OLDSMAR, Fla., July 10, 2020 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2020.

Key Points: 
  • OLDSMAR, Fla., July 10, 2020 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2020.
  • Consolidated revenues for the second quarter of fiscal 2020 were $7.87 million compared to $8.13 million for the second quarter of fiscal 2019, a 3% decrease.
  • More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their babys cord blood and cord tissue stem cells.
  • Besides being AABB accredited as a cord blood facility, Cryo-Cell was also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization.

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2020 Financial Results

Retrieved on: 
Tuesday, April 14, 2020
Branches of biology, Biology, Stem cells, Life sciences, Blood, Cryo-Cell International, Childbirth, Cord blood bank, Cloning, Cord blood, Cryo-Save, Relicord

OLDSMAR, Fla., April 14, 2020 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 29, 2020.

Key Points: 
  • OLDSMAR, Fla., April 14, 2020 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 29, 2020.
  • Consolidated revenues for the first quarter of fiscal 2020 were $7.62 million compared to $7.50 million for the first quarter of fiscal 2019, a 2% increase.
  • More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their babys cord blood and cord tissue stem cells.
  • Besides being AABB accredited as a cord blood facility, Cryo-Cell was also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization.

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2019 Financial Results

Retrieved on: 
Tuesday, October 15, 2019
Branches of biology, Stem cells, Biology, Life sciences, Blood, Cryo-Cell International, Childbirth, Cord blood bank, Cloning, Cord blood, Cryo-Save, Relicord

OLDSMAR, Fla., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2019.

Key Points: 
  • OLDSMAR, Fla., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the Company), the worlds first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2019.
  • Consolidated revenues for the third quarter of fiscal 2019 were $8.2 million compared to $7.9 million for the third quarter of fiscal 2018.
  • More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their babys cord blood and cord tissue stem cells.
  • Besides being AABB accredited as a cord blood facility, Cryo-Cell was also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization.